Mariia Ivanova, transl. “Guideline Summary NGC (2016): Canagliflozin, Dapagliflozin and Empagliflozin As Monotherapies for Treating Type 2 Diabetes”. KIDNEYS, no. 4.18, Sept. 2021, p. 36, doi:10.22141/2307-1257.4.18.2016.84326.